Acquired Aplastic Anemia Therapies: Immunosuppressive Therapy Versus Alternative Donor Hematopoietic Cell Transplantation

Overview

Journal J Hematol

Specialty Hematology

Date 2024 Jul 12

PMID 38993743

Authors

Baldeep Wirk

Affiliations

Soon will be listed here.

Abstract

Immunosuppressive therapy for acquired severe aplastic anemia improves pancytopenia but has a significant risk of relapse (40%) and clonal evolution to myeloid neoplasms (15%), especially in patients older than 40. Yet, current guidelines for newly diagnosed severe aplastic anemia patients over the age of 40 recommend immunosuppressive therapy instead of curative allogeneic stem cell transplantation. Upfront allogeneic stem cell transplants are restricted to the rare patient who is not only young but also has a matched sibling donor. This article will discuss practice-changing data on the recent advances in upfront alternative donor hematopoietic cell transplants that could rewrite current treatment algorithms.

References

Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel S, Cook R, Griffin M . Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia. N Engl J Med. 2022; 386(1):11-23. DOI: 10.1056/NEJMoa2109965. View

Gurnari C, Pagliuca S, Prata P, Galimard J, Catto L, Larcher L . Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria. J Clin Oncol. 2022; 41(1):132-142. PMC: 10476808. DOI: 10.1200/JCO.22.00710. View

Gurnari C, Pagliuca S, Maciejewski J . Clonal evolution in aplastic anemia: failed tumor surveillance or maladaptive recovery?. Leuk Lymphoma. 2023; 64(8):1389-1399. PMC: 11104022. DOI: 10.1080/10428194.2023.2215614. View

Mizumaki H, Hosomichi K, Hosokawa K, Yoroidaka T, Imi T, Zaimoku Y . A frequent nonsense mutation in exon 1 across certain HLA-A and -B alleles in leukocytes of patients with acquired aplastic anemia. Haematologica. 2020; 106(6):1581-1590. PMC: 8168509. DOI: 10.3324/haematol.2020.247809. View

Babushok D, Duke J, Xie H, Stanley N, Atienza J, Perdigones N . Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal Complications. Blood Adv. 2017; 1(22):1900-1910. PMC: 5621748. DOI: 10.1182/bloodadvances.2017010918. View

Xu Z, Xu L, Wu D, Wang S, Zhang X, Xi R . Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based study. Haematologica. 2022; 107(12):2918-2927. PMC: 9713560. DOI: 10.3324/haematol.2022.280758. View

Luzzatto L, Bessler M, Rotoli B . Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise?. Cell. 1997; 88(1):1-4. DOI: 10.1016/s0092-8674(00)81850-4. View

Townsley D, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O . Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. N Engl J Med. 2017; 376(16):1540-1550. PMC: 5548296. DOI: 10.1056/NEJMoa1613878. View

Salvatore D, Labopin M, Ruggeri A, Battipaglia G, Ghavamzadeh A, Ciceri F . Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the.... Haematologica. 2018; 103(8):1317-1328. PMC: 6068036. DOI: 10.3324/haematol.2018.189258. View

10.

DeZern A, Eapen M, Wu J, Talano J, Solh M, Davila Saldana B . Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial. Lancet Haematol. 2022; 9(9):e660-e669. PMC: 9444987. DOI: 10.1016/S2352-3026(22)00206-X. View

11.

Shin S, Jeon Y, Yoon J, Yahng S, Lee S, Cho B . Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning. Bone Marrow Transplant. 2016; 51(11):1456-1463. DOI: 10.1038/bmt.2016.171. View

12.

DeZern A, Zahurak M, Symons H, Cooke K, Huff C, Jain T . Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia. Blood. 2023; 141(25):3031-3038. DOI: 10.1182/blood.2023020435. View

13.

Bolanos-Meade J, Fuchs E, Luznik L, Lanzkron S, Gamper C, Jones R . HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood. 2012; 120(22):4285-91. PMC: 3507140. DOI: 10.1182/blood-2012-07-438408. View

14.

DeZern A, Zahurak M, Symons H, Cooke K, Rosner G, Gladstone D . Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide. Blood Adv. 2020; 4(8):1770-1779. PMC: 7189283. DOI: 10.1182/bloodadvances.2020001729. View

15.

DAMESHEK W . Riddle: what do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and "hypoplastic" leukemia have in common?. Blood. 1967; 30(2):251-4. View

16.

Marsh J, Risitano A, Mufti G . The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic Anemia. Biol Blood Marrow Transplant. 2019; 25(9):e277-e284. DOI: 10.1016/j.bbmt.2019.05.012. View

17.

Zaimoku Y, Takamatsu H, Hosomichi K, Ozawa T, Nakagawa N, Imi T . Identification of an HLA class I allele closely involved in the autoantigen presentation in acquired aplastic anemia. Blood. 2017; 129(21):2908-2916. DOI: 10.1182/blood-2016-11-752378. View

18.

Clay J, Kulasekararaj A, Potter V, Grimaldi F, McLornan D, Raj K . Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia. Biol Blood Marrow Transplant. 2014; 20(11):1711-6. DOI: 10.1016/j.bbmt.2014.06.028. View

19.

Ogawa S . Clonal hematopoiesis in acquired aplastic anemia. Blood. 2016; 128(3):337-47. PMC: 5054460. DOI: 10.1182/blood-2016-01-636381. View

20.

Sugimori C, Yamazaki H, Feng X, Mochizuki K, Kondo Y, Takami A . Roles of DRB1 *1501 and DRB1 *1502 in the pathogenesis of aplastic anemia. Exp Hematol. 2007; 35(1):13-20. DOI: 10.1016/j.exphem.2006.09.002. View